• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA Publishes 6 Regulatory Drafts Concerning Clinical Trials for Medical Devices and IVDs

NMPA Publishes 6 Regulatory Drafts Concerning Clinical Trials for Medical Devices and IVDs

Thursday, 27 May 2021 / Published in Medical Device, News, NMPA Registration in China

NMPA Publishes 6 Regulatory Drafts Concerning Clinical Trials for Medical Devices and IVDs

On May 10, 2021, the NMPA (National Medical Products Administration) published 6 regulatory draft documents concerning clinical trials for medical devices and IVDs:

  • Medical device clinical trial protocol template (Draft)
  • Medical device clinical trial report template (Draft)
  • In vitro diagnostic reagent clinical trial protocol template (Draft)
  • In vitro diagnostic reagent clinical trial report template (Draft)
  • Sample report form for serious adverse events in clinical trials of medical devices/in vitro diagnostic reagents (Draft)
  • Basic catalogue documents for clinical trials of medical devices (Draft)

The NMPA is currently soliciting public comments on the draft documents. The public consultation period is open until May 30, 2021.

Highlights

  • Covers the unified clinical trial test protocols and report format of IVD reagents
  • Heavily focuses on the procedures and requirements for reporting adverse events during clinical trials
  • Formulate a standardized directory using the data traceability of clinical trials
  • Identify items for improvements and blind spots from previous clinical trials, and propose actions to improve

By Jacky Li and Colleen Xu. Contact Cisema if you would like to learn more.

Tagged under: Clinical Trials, IVDs

What you can read next

32 Food Ingredients, Food Additives, and Food-Related Products Officially Approved in China
Advertisement of Life Science Products
Pilot Plan of the UDI System in Hainan Launched

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.